Share-based Payment Arrangement, Expense in USD of IRADIMED CORP from Q2 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IRADIMED CORP quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q2 2013 to Q3 2025.
  • IRADIMED CORP Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $666,083, a 5.7% increase year-over-year.
  • IRADIMED CORP Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,879,601, a 19% increase year-over-year.
  • IRADIMED CORP annual Share-based Payment Arrangement, Expense for 2024 was $2,524,536, a 15% increase from 2023.
  • IRADIMED CORP annual Share-based Payment Arrangement, Expense for 2023 was $2,186,909, a 57% increase from 2022.
  • IRADIMED CORP annual Share-based Payment Arrangement, Expense for 2022 was $1,394,106, a 4.5% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IRADIMED CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,879,601 $666,083 +$36,119 +5.7% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $2,843,482 $730,618 +$121,522 +20% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $2,721,960 $826,064 +$197,424 +31% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $2,524,536 $656,836 +$105,772 +19% 01 Oct 2024 31 Dec 2024 10-K/A 03 Sep 2025 2024 FY
Q3 2024 $2,418,764 $629,964 +$96,216 +18% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $2,322,548 $609,096 +$40,642 +7.2% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025 2025 Q2
Q1 2024 $2,281,906 $628,640 +$94,997 +18% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q4 2023 $2,186,909 $551,064 +$124,509 +29% 01 Oct 2023 31 Dec 2023 10-K/A 03 Sep 2025 2024 FY
Q3 2023 $2,062,400 $533,748 +$140,560 +36% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $1,921,840 $568,454 +$447,451 +370% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $1,474,389 $533,643 +$80,283 +18% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $1,394,106 $426,555 +$34,771 +8.9% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 $1,359,335 $393,188 +$31,352 +8.7% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $1,327,983 $121,003 -$237,009 -66% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $1,564,992 $453,360 +$105,619 +30% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $1,459,373 $391,784 +$73,878 +23% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $1,385,495 $361,836 -$54,689 -13% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $1,440,184 $358,012 -$2,300,620 -87% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $3,740,804 $347,741 -$221,217 -39% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $3,962,021 $317,906 -$230,629 -42% 01 Oct 2020 31 Dec 2020 10-K 04 Mar 2022 2021 FY
Q3 2020 $4,192,650 $416,525 -$39,116 -8.6% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $4,231,766 $2,658,632 +$2,190,196 +468% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $2,041,570 $568,958 +$186,605 +49% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $1,854,965 $548,535 +$146,180 +36% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
Q3 2019 $1,708,785 $455,641 -$47,915 -9.5% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $1,756,700 $468,436 +$26,355 +6% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $1,730,345 $382,353 -$33,974 -8.2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $1,764,319 $402,355 -$316,930 -44% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2021 2020 FY
Q3 2018 $2,081,249 $503,556 -$409,719 -45% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $2,490,968 $442,081 -$3,298 -0.74% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $2,494,266 $416,327 +$39,903 +11% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $2,454,363 $719,285 +$665,429 +1236% 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2020 2019 FY
Q3 2017 $1,788,934 $913,275 +$720,819 +375% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $1,068,115 $445,379 -$759,027 -63% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $1,827,142 $376,424 -$14,759 -3.8% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $1,841,901 $53,856 -$253,029 -82% 01 Oct 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
Q3 2016 $2,094,930 $192,456 -$138,692 -42% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 $2,233,622 $1,204,406 +$897,352 +292% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2017 2017 Q2
Q1 2016 $1,336,270 $391,183 +$116,152 +42% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $1,220,118 $306,885 +$86,703 +39% 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
Q3 2015 $1,133,415 $331,148 +$159,549 +93% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $973,866 $307,054 +$137,581 +81% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $836,285 $275,031 +$112,222 +69% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $724,063 $220,182 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
Q3 2014 $171,599 +$103,619 +152% 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 $169,473 +$101,493 +149% 01 Apr 2014 30 Jun 2014 10-Q 11 Aug 2015 2015 Q2
Q1 2014 $162,809 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q3 2013 $67,980 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2014 Q3
Q2 2013 $67,980 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2

IRADIMED CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,524,536 +$337,627 +15% 01 Jan 2024 31 Dec 2024 10-K/A 03 Sep 2025 2024 FY
2023 $2,186,909 +$792,803 +57% 01 Jan 2023 31 Dec 2023 10-K/A 03 Sep 2025 2024 FY
2022 $1,394,106 -$65,267 -4.5% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024 2023 FY
2021 $1,459,373 -$2,502,648 -63% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $3,962,021 +$2,107,056 +114% 01 Jan 2020 31 Dec 2020 10-K 04 Mar 2022 2021 FY
2019 $1,854,965 +$90,646 +5.1% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
2018 $1,764,319 -$690,044 -28% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2021 2020 FY
2017 $2,454,363 +$612,462 +33% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2020 2019 FY
2016 $1,841,901 +$621,783 +51% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $1,220,118 +$496,055 +69% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $724,063 +$452,144 +166% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $271,919 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.